T Cell


Gamma Delta Work Makes Cautious Inroads into Clinic

Jacob Plieth of Evaluate writes about TC Biopharm's treatment of the first patient cohort in a study of OmnImmune (TCB002), which represents the fourth clinical trial involving gamma-delta cells in the West. The UK biotech venture reports that the trial is a prelude...

Tackling T Cells: A Path to Hope

Nancy Fleisler writing for Harvard Medical School reports on Harvard Medical School and Boston Children’s Hospital studies focused on T cells are a path toward reducing organ transplant rejection and treating autoimmune diseases. There are two kinds of T cells...

Pin It on Pinterest